From Name:
From Email:
To Name:
To Email:

Optional Message:


Bone medication, esophageal cancers linked

from MedPage Today

The esophageal cancer risk with bisphosphonate bone drugs may be a bigger problem than thought, particularly with use of alendronate, an adverse event surveillance study suggested. Overall, 128 cases of bisphosphonate-associated esophageal cancer were reported to the FDA's adverse event reporting system from 1995 through 2010, Northwestern University researchers found. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063